Allele1 | Â | Â | Allele2 | Â | Â | Â | |
---|---|---|---|---|---|---|---|
Nucleotide change | Consequence or amino change | Category | Nucleotide change | Consequence or amino change | Category | Number of patients | |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.IVS7-2A > G | aberrant splicing | Pathogenic | 4 | EVA |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.IVS7-2A > G | aberrant splicing | Pathogenic | 1 | nl |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.754 T > C | S252P | Pathogenic | 1 | ND |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.1548insC | FX517,526X | Pathogenic | 1 | EVA |
c.2168A > G | H723R | Pathogenic | c.1079 T > C | A360V | Pathogenic | 1 | EVA |
c.2168A > G | H723R | Pathogenic | c.84C > A | S28R | Pathogenic | 1 | nl |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.1975G > C | V659L | Pathogenic | 1 | EVA |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.IVS9 + 1G > A | aberrant splicing | Pathogenic | 2 | EVA |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.2265C > A | T755T | Silent variant | 1 | EVA |
c.IVS7-2A > G | aberrant splicing | Pathogenic | c.IVS5 + 27 T > C | Variant in intron | Unclassified variant | 1 | EVA |
c.1548insC | FX517,526X | Pathogenic | c.IVS11 + 47 T > C | Variant in intron | Unclassified variant | 1 | EVA |
c.2168A > G | H723R | Pathogenic |  |  |  | 1 | EVA |
c.IVS7-2A > G | aberrant splicing | Pathogenic |  |  |  | 3 | nl |
c.IVS7-2A > G | aberrant splicing | Pathogenic |  |  |  | 1 | EVA |
c.intron6-75_ 76 insTGTG | aberrant splicing | Unclassified variant | Â | Â | Â | 1 | nl |
c.IVS7 + 35A > G | Variant in intron | Unclassified variant |  |  |  | 1 | nl |
c.IVS7 + 40G > A | Variant in intron | Unclassified variant |  |  |  | 1 | nl |
WT | Â | Â | WT | Â | Â | 2 | EVA |